Skip to main content

Together we are beating cancer

Donate now
  • Policy & Insight

Health is wealth: tackling cancer to grow the economy

by Annalisa Belloni | Analysis

27 June 2025

1 comment 1 comment

Houses Of Parliament
mistervlad/Shutterstock.com

Cancer is the leading cause of death in the UK, and it claims more than 160,000 lives each year. But numbers like that can only tell us so much. There’s no database that records the precious moments missed or the words left unsaid because of cancer – no way to measure what it actually means to lose even one person to the disease. 

What statistics do is help us understand how we can stop cancer taking so much away. In that respect, thinking about cancer in terms of economics can be especially powerful. Researching, treating, diagnosing and even preventing cancer all take investment. Using economic analysis, we can ensure that every pound we spend leads to the greatest return for people affected by or at risk of the disease.

And, taking an even wider view, if we can work out how much of an economic burden cancer puts on the UK today, we can also make a much clearer and more compelling case for the extra government investment we need to drive significant progress.

Until now, the actual economic impact of cancer in the UK has been unclear and under-researched. We’ve been working to change that, and today, we published our new analysis of the cost of the lives lost to cancer in the UK and a wider study we commissioned into the many ways cancer can impact the economy. Together, these two papers show how transforming cancer care could help bring the UK wealth, as well as health. 

Analysing the cost of cancer deaths  

For the analysis we published today, we used the latest and best available data to calculate that the UK economy loses £10.3bn each year due to people dying of cancer. This is based on the economic contribution individuals are expected to have made through work if their lives had not been cut short.  

This calculation makes it clear that cancer stands out as the leading cause of economic loss due to mortality, ahead of all other health conditions. That’s linked to the fact that, as well as being the biggest cause of death in the UK, cancer also affects people of all ages.  

A bar chart showing that deaths from cancer cause a larger productivity loss (measured in billions of pounds) than deaths from any other illness.

Cancer deaths in younger adults have a particularly high economic impact because they represent a larger loss in potential years of life. In 2023, a collective 119,000 years were taken from the future working lives of adults under 50, amounting to £3.2bn in lost output. 

Why do we need economics to focus on cancer?  

When we talk about economic growth, we often think about new technology, infrastructure or investment. But one of the most powerful drivers of prosperity is often overlooked: health. A healthier population doesn’t just mean happier and more fulfilled lives, it also helps the economy thrive, which is why it should be at the centre of the political agenda.  

Economics shows us the benefits of making changes and the costs of standing still. It gives us the tools to look at how to get the best results for our money and show that protecting people’s health isn’t a cost, it’s an investment. By demonstrating the economic impact of cancer, we can help policymakers see that health and the economy are interlinked – and that saving lives pays off, not just in moral terms, but economic terms too.  

The cost of living: looking beyond cancer deaths

The effect of premature deaths from cancer represents just one way the disease affects the economy.  

In order to gain a more holistic understanding, we also commissioned academics at the University of Leeds to conduct a comprehensive review of all the existing evidence about the wide-ranging costs associated with cancer.  

That led to our new Cost of cancer in the UK report, which explores the many ways cancer can have a financial and economic impact. These include costs to the healthcare system, which pays to diagnose, treat and care for people with cancer, to patients themselves, who may have to pay to travel long distances to hospital, and to the wider economy.

Strikingly, the review estimates that the UK loses £5bn or more every year because of the difficulties of living with cancer, with inability to work due to cancer costing £1-1.7bn each year and informal caregiving adding a further £4-4.5bn.

The report also identifies critical evidence gaps, particularly around the long-term financial impact on patients, and highlights the limitations of the current evidence on cancer’s direct cost to the healthcare system and specific population groups. 

Drawing on what we’ve learned from both of these economic research projects, we’ve developed a series of recommendations for what the Government can do to reduce the human and economic burden of cancer.

Our calls to government

1. Introduce preventative measures to tackle the causes of cancer 

The best way to limit the impact of cancer is to stop the disease before it starts. Government action to tackle key cancer risk factors – especially smoking and obesity – can reduce avoidable illness, support economic growth and reduce pressure on the NHS.  

2. Improve early diagnosis  

We know that early diagnosis is one of the most effective ways to increase cancer survival and give people more years of productive life. In some cases, cancers detected at an earlier stage also cost less for the health service to treat. 

To reduce the number of people diagnosed with cancer at a later stage (stage 3 and 4), governments and health systems will need to roll out and optimise evidence-based cancer screening programmes, increase the capacity of the diagnostic workforce and lay the groundwork for future innovations in cancer detection and diagnosis. 

3. Increase investment and support for research  

Research connects every aspect of the effort to lessen the burden of cancer. It’s key to improving how we prevent, diagnose and treat the disease, and, in doing so, it brings significant economic benefits. In the long-term, investing in research may have the biggest impact of all. 

4. Promote better access, linkage and use of data  

There’s also an urgent need to leverage data to help power research. While the UK collects extensive and high-quality patient data, researchers often face difficulties accessing and effectively utilising the datasets they need to uncover new insights about how to prevent, diagnose, and treat cancer. 

If delivered effectively, with a relentless focus on the needs and concerns of researchers, patients and the wider public, the Government’s recently announced £600m investment in a Health Data Research Service could be a big step in the right direction.

5. Prioritise collaboration and partnership  

Finally, the Government will need to work with the right partners to fill key knowledge gaps around the cost of cancer.  

This will require collaborative, multi-disciplinary research supported by greater investment to bring together data within and beyond the health system and focus in on patient-experienced costs and variation between patient groups. This is crucial for guiding effective policy and ensuring public funding achieves the greatest possible impact. 

Cancer touches every part of our society and has huge economic implications. By recognising this – and acting accordingly – we can harness the huge potential for both our health and wealth and deliver longer, better lives, free from the fear of cancer for people across the UK.

    Comments

  • Andy Anderson
    18 July 2025

    I run The Patient Cancer Support Group which is a small Charity in Surrey and through our meetings and patients experiences (I’m a cancer patient myself) I have become more aware of the huge financial costs involved but also the human costs. I hope the government will order a review because all that summarised most certainly need to be addressed if we are going to move forward.

Tell us what you think

Leave a Reply

Your email address will not be published. Required fields are marked *

Read our comment policy.

    Comments

  • Andy Anderson
    18 July 2025

    I run The Patient Cancer Support Group which is a small Charity in Surrey and through our meetings and patients experiences (I’m a cancer patient myself) I have become more aware of the huge financial costs involved but also the human costs. I hope the government will order a review because all that summarised most certainly need to be addressed if we are going to move forward.

Tell us what you think

Leave a Reply

Your email address will not be published. Required fields are marked *

Read our comment policy.